Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.
Atherosclerosis
Atherosclerosis
Article
Statins and Insulin Resistance
Read time: 1h 1m 1s
About
Media
Watch time: 4m 57s
Articles
The Effects of Plant Stanol Ester in Different Subject Groups
Citation:
European Cardiology 2010;6(3):18–21
- Views:
329
- Downloads:
0
Prevention of Cardiovascular Risk in Diabetic Patients - An Update
Citation:
European Cardiology Review 2007;2(2):27–9
- Views:
96
- Downloads:
0
Cardiovascular Risk Reduction in Childhood - Evidence and Strategies
Citation:
European Cardiology 2009;5(2):34–9
- Views:
173
- Downloads:
0
Advances in the Invasive Diagnosis and Treatment of Vulnerable Coronary Plaques
Citation:
European Cardiology 2008;4(1):105–10
- Views:
148
- Downloads:
0